Cory Kasimov
Stock Analyst at Evercore ISI
(4.89)
# 315
Out of 4,600 analysts
999
Total ratings
60.1%
Success rate
19.4%
Average return
Main Sectors:
Stocks Rated by Cory Kasimov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $400 → $325 | $228.82 | +42.03% | 7 | Aug 5, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $130 | $92.00 | +41.30% | 32 | Aug 5, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $45 | $27.36 | +64.47% | 8 | Aug 5, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $535 | $484.08 | +10.52% | 61 | Aug 4, 2026 | |
| ORIC ORIC Pharmaceuticals | Maintained: Buy | $25 | $13.41 | +86.50% | 5 | Aug 4, 2026 | |
| EWTX Edgewise Therapeutics | Maintained: Buy | $45 → $55 | $45.01 | +22.21% | 9 | Jul 20, 2026 | |
| COAG Hemab Therapeutics Holdings | Initiated Coverage: Buy | $50 | $48.60 | +2.88% | 1 | May 26, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $120 | $60.60 | +98.02% | 83 | May 21, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Buy | $200 → $210 | $164.40 | +27.74% | 16 | May 18, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $875 → $825 | $773.34 | +6.68% | 77 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $25.33 | +57.92% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $12.41 | +101.53% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $80 | $64.35 | +24.32% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $47.79 | +36.01% | 1 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $130 | $82.23 | +58.09% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $9.16 | +96.61% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $195.10 | +2.51% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 → $50 | $57.87 | -13.59% | 48 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 | $13.61 | +149.82% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $78.98 | +1.29% | 10 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $15 | $6.74 | +122.55% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $31.88 | +72.52% | 7 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $126 → $128 | $25.32 | n/a | 47 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 → $84 | $16.10 | n/a | 26 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $33 | $50.64 | n/a | 48 | Jul 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $219 → $221 | $208.60 | n/a | 74 | Jul 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 | $28.80 | n/a | 48 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $11 | $3.49 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $20 | $1.96 | n/a | 17 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $19 → $16 | $2.82 | n/a | 25 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $235 → $227 | $409.16 | n/a | 62 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $98 → $86 | $120.74 | n/a | 54 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 | $19.42 | n/a | 8 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $15.93 | n/a | 3 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $74 | $130.51 | n/a | 59 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $8.01 | n/a | 38 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $89.33 | n/a | 1 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $48.56 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $0.5083 | n/a | 13 | Jun 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $4.04 | n/a | 14 | May 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $384 → $100 | $1,143.70 | n/a | 2 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $281.47 | $8.73 | n/a | 1 | Dec 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $0.089 | n/a | 6 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.93 | n/a | 7 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.95 | n/a | 1 | Sep 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $7.71 | n/a | 6 | Aug 11, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $68 | $54.45 | n/a | 5 | Jun 8, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $361.23 | n/a | 1 | Jan 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $18 | $9.14 | n/a | 2 | Dec 9, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $24 → $20 | $0.0001 | n/a | 2 | May 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $41.99 | n/a | 1 | Jun 4, 2013 |
Alnylam Pharmaceuticals
Aug 5, 2026
Maintained: Buy
Price Target: $400 → $325
Current: $228.82
Upside: +42.03%
BioNTech SE
Aug 5, 2026
Maintained: Buy
Price Target: $130
Current: $92.00
Upside: +41.30%
Beam Therapeutics
Aug 5, 2026
Maintained: Buy
Price Target: $45
Current: $27.36
Upside: +64.47%
Vertex Pharmaceuticals
Aug 4, 2026
Maintained: Buy
Price Target: $535
Current: $484.08
Upside: +10.52%
ORIC Pharmaceuticals
Aug 4, 2026
Maintained: Buy
Price Target: $25
Current: $13.41
Upside: +86.50%
Edgewise Therapeutics
Jul 20, 2026
Maintained: Buy
Price Target: $45 → $55
Current: $45.01
Upside: +22.21%
Hemab Therapeutics Holdings
May 26, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $48.60
Upside: +2.88%
BioMarin Pharmaceutical
May 21, 2026
Maintained: Buy
Price Target: $120
Current: $60.60
Upside: +98.02%
Neurocrine Biosciences
May 18, 2026
Maintained: Buy
Price Target: $200 → $210
Current: $164.40
Upside: +27.74%
Regeneron Pharmaceuticals
May 18, 2026
Maintained: Buy
Price Target: $875 → $825
Current: $773.34
Upside: +6.68%
May 13, 2026
Maintained: Buy
Price Target: $40
Current: $25.33
Upside: +57.92%
May 12, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $12.41
Upside: +101.53%
May 8, 2026
Maintained: Buy
Price Target: $55 → $80
Current: $64.35
Upside: +24.32%
May 8, 2026
Maintained: Buy
Price Target: $65
Current: $47.79
Upside: +36.01%
May 8, 2026
Maintained: Buy
Price Target: $125 → $130
Current: $82.23
Upside: +58.09%
May 7, 2026
Maintained: Buy
Price Target: $18
Current: $9.16
Upside: +96.61%
May 7, 2026
Maintained: Buy
Price Target: $200
Current: $195.10
Upside: +2.51%
May 4, 2026
Maintained: Hold
Price Target: $35 → $50
Current: $57.87
Upside: -13.59%
May 1, 2026
Maintained: Buy
Price Target: $34
Current: $13.61
Upside: +149.82%
Apr 1, 2026
Maintained: Buy
Price Target: $80
Current: $78.98
Upside: +1.29%
Mar 27, 2026
Downgraded: Hold
Price Target: $40 → $15
Current: $6.74
Upside: +122.55%
Mar 17, 2026
Maintained: Buy
Price Target: $55
Current: $31.88
Upside: +72.52%
Jul 29, 2022
Maintained: Buy
Price Target: $126 → $128
Current: $25.32
Upside: n/a
Jul 28, 2022
Maintained: Hold
Price Target: $91 → $84
Current: $16.10
Upside: n/a
Jul 27, 2022
Maintained: Hold
Price Target: $30 → $33
Current: $50.64
Upside: n/a
Jul 20, 2022
Maintained: Hold
Price Target: $219 → $221
Current: $208.60
Upside: n/a
Jun 21, 2022
Downgraded: Hold
Price Target: $19
Current: $28.80
Upside: n/a
May 10, 2022
Maintained: Hold
Price Target: $14 → $11
Current: $3.49
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $24 → $20
Current: $1.96
Upside: n/a
May 4, 2022
Maintained: Sell
Price Target: $19 → $16
Current: $2.82
Upside: n/a
Apr 28, 2022
Maintained: Hold
Price Target: $235 → $227
Current: $409.16
Upside: n/a
Feb 9, 2022
Maintained: Hold
Price Target: $98 → $86
Current: $120.74
Upside: n/a
Nov 19, 2021
Maintained: Buy
Price Target: $61
Current: $19.42
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: n/a
Current: $15.93
Upside: n/a
Apr 29, 2021
Maintained: Hold
Price Target: $74
Current: $130.51
Upside: n/a
Feb 25, 2021
Maintained: Sell
Price Target: n/a
Current: $8.01
Upside: n/a
Jul 15, 2020
Downgraded: Sell
Price Target: n/a
Current: $89.33
Upside: n/a
Nov 13, 2019
Maintained: Buy
Price Target: n/a
Current: $48.56
Upside: n/a
Jun 26, 2018
Maintained: Sell
Price Target: n/a
Current: $0.5083
Upside: n/a
May 11, 2017
Reiterated: Sell
Price Target: n/a
Current: $4.04
Upside: n/a
Apr 11, 2017
Maintained: Buy
Price Target: $384 → $100
Current: $1,143.70
Upside: n/a
Dec 15, 2015
Reiterated: Buy
Price Target: $281.47
Current: $8.73
Upside: n/a
Dec 2, 2015
Rated: Buy
Price Target: $16
Current: $0.089
Upside: n/a
Oct 30, 2015
Reiterated: Hold
Price Target: n/a
Current: $1.93
Upside: n/a
Sep 2, 2015
Initiated Coverage: Buy
Price Target: $20
Current: $1.95
Upside: n/a
Aug 11, 2015
Reiterated: Buy
Price Target: $10 → $14
Current: $7.71
Upside: n/a
Jun 8, 2015
Maintained: Hold
Price Target: $65 → $68
Current: $54.45
Upside: n/a
Jan 13, 2015
Maintained: Hold
Price Target: n/a
Current: $361.23
Upside: n/a
Dec 9, 2014
Rated: Buy
Price Target: $20 → $18
Current: $9.14
Upside: n/a
May 7, 2014
Rated: Buy
Price Target: $24 → $20
Current: $0.0001
Upside: n/a
Jun 4, 2013
Downgraded: Hold
Price Target: n/a
Current: $41.99
Upside: n/a